Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

Author： Mougalian Sarah S. Soulos Pamela R. Killelea Brigid K. Lannin Donald R. Abu-Khalaf Maysa M. DiGiovanna Michael P. Sanft Tara B. Pusztai Lajos Gross Cary P. Chagpar Anees B.

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|15|2544-2552

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.15, 2015-08, pp. : 2544-2552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Chemotherapy in Stage III NSCLC

By Allen Jeffrey Jahanzeb Mohammad

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 285-293

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Neoadjuvant chemotherapy for early breast cancer

By Mieog J Sven D van de Velde Cornelis JH

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1423-1434

Informa Healthcare

Access to resources Recommend Favorite

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

By Griffiths Robert I. Barron Richard L.

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 103-118

Adis International

Access to resources Recommend Favorite

Serum Tumor Markers in Stage I-II Breast Cancer

Medicinal Chemistry, Vol. 12, Iss. 3, 2016-05 ,pp. : 285-289

Bentham Science Publishers

Access to resources Recommend Favorite

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D Sarkar Tarun Hutcheon Andrew W

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite